The nationwide lockdown has completed two months, but gradually there has been easing in lockdown measures in green and orange zones with strict guidelines, including compulsory wearing of a face mask.
On the contrary, the new infections have been consistently rising as India reported more than 1.3 lakh confirmed infected cases with more than 3,800 deaths.
This remains a risk for the market and as a result, the upside for benchmark indices remain capped. Nifty50 has been moving in a wide range of 1,000 points after showing strong recovery from March-lows, and failed to surpass 10,000-mark yet, while the BSE Sensex has been ranging in 3,000 points.
The BSE Sensex gained 20 percent from March lows, and rallied 15 percent during the lockdown period so far. BSE Midcap index rose 14 percent and Smallcap surged 18.5 percent. Majority of sectoral indices gained in double digits but Bankex rose just 1.4 percent and realty index fell 3 percent.
Talking about stock-specific action, 65 percent of all BSE stocks traded in the green. Meanwhile, 80 percent of scrips in the BSE 500 index traded higher. Of which 300 stocks witnessed double-digit gains.
The list includes Jubilant Life, Glenmark Pharma, Infibeam Avenues, Alembic Pharma, HEG, Cipla, ICICI Securities, Graphite India, Parag Milk Foods, RCF, Vodafone Idea, ITI, Syngene International, M&M, Muthoot Finance and Rail Vikas Nigam.
Amongst them, top 2 stocks - Aurobindo Pharma and Hathway Cable were multibaggers with gain of more than 100 percent in lockdown period.
Stock cash tips , Equity tips , MCX tips
For Quick Trial – 91091 93302
or mail us here: info@moneyplantresearch.com
or visit https://www.moneyplantresearch.com
No comments:
Post a Comment